XML 39 R27.htm IDEA: XBRL DOCUMENT

INTANGIBLE ASSETS, NET (Tables)

9 Months Ended

Sep. 30, 2016

Intangible Assets, Net (Excluding Goodwill) [Abstract]

Schedule of intangible assets

The following table sets forth the gross carrying amount and accumulated amortization of our intangible assets as of September 30, 2016 and December 31, 2015:

		September 30, 2016
		Gross Carrying Amount				Accumulated Amortization				Net Amount				Weighted- Average Remaining Amortization Period (yrs.)
Amortizing intangible assets:
OPERA^®software patent		$	31,951			$	(5,991	)		$	25,960				13
Development costs of corporate website			91,743				(91,743	)			—				n/a
Approved hormone therapy drug candidate patents			959,059				(86,907	)			872,152				16.25
Hormone therapy drug candidate patents (pending)			1,037,829				—				1,037,829				n/a
Non-amortizing intangible assets:
Multiple trademarks			182,437				—				182,437				indefinite
TOTAL		$	2,303,019			$	(184,641	)		$	2,118,378

		December 31, 2015
		Gross Carrying Amount				Accumulated Amortization				Net Amount				Weighted- Average Remaining Amortization Period (yrs.)
Amortizing intangible assets:
OPERA^®software patent		$	31,951			$	(4,493	)		$	27,458				13.75
Development costs of corporate website			91,743				(91,743	)			—				n/a
Approved hormone therapy drug candidate patents			705,752				(49,845	)			655,907				17
Hormone therapy drug candidate patents (pending)			774,165				—				774,165				n/a
Non-amortizing intangible assets:
Multiple trademarks			157,721				—				157,721				indefinite
TOTAL		$	1,761,332			$	(146,081	)		$	1,615,251

Schedule of estimated amortization expense

Estimated amortization expense for the next five years is as follows:

Year Ending December 31,				Estimated Amortization
	2016 (3 months)			$	13,917
	2017			$	55,668
	2018			$	55,668
	2019			$	55,668
	2020			$	55,668